Filter Results:
(792)
Show Results For
- All HBS Web
(1,551)
- People (1)
- News (333)
- Research (792)
- Multimedia (8)
- Faculty Publications (573)
Show Results For
- All HBS Web
(1,551)
- People (1)
- News (333)
- Research (792)
- Multimedia (8)
- Faculty Publications (573)
Sort by
- March 2001 (Revised July 2004)
- Case
Adecco SA's Acquisition of Olsten Corp
In the summer of 1999, Adecco SA, one of the world's leading staffing companies, was in the midst of attempting to acquire the staffing operations of Olsten Corp., a U.S. firm. This case analyzes the economics of the staffing industry, basic valuation, cross-border... View Details
Keywords: Financial Condition; Acquisition; Cross-Cultural and Cross-Border Issues; Service Industry; United States
Kedia, Simi, and Peter Tufano. "Adecco SA's Acquisition of Olsten Corp." Harvard Business School Case 201-068, March 2001. (Revised July 2004.)
- 25 Apr 2000
- Research & Ideas
Adjusting the Fit for Government
The role of government in Africa must be to establish an "investor friendly" environment, according to Obiageli Ezekwesili, a panelist at the Africa Business Conference's debate on "Government and the Enabling Environment." As View Details
Keywords: by Martha Lagace
- 17 May 2016
- First Look
May 17, 2016
2016 New York: Oxford University Press Consumers, Corporations, and Public Health: A Case-Based Approach to Sustainable Business By: John A. Quelch. Abstract—The public health footprint associated with corporate behavior has come under... View Details
Keywords: Sean Silverthorne
- February 1990 (Revised March 1990)
- Case
Quantum Semiconductor, Inc.
By: Janice H. Hammond and Roy D. Shapiro
Quantum is faced with a difficult ethical dilemma--industry studies provide evidence that chemicals used in semiconductor manufacturing may cause women working in fabrication cleanrooms to suffer a higher likelihood of spontaneous abortions. The possibility of other... View Details
Keywords: Safety; Prejudice and Bias; Law; Equality and Inequality; Cost; Production; Ethics; Health; Gender; Semiconductor Industry
Hammond, Janice H., and Roy D. Shapiro. "Quantum Semiconductor, Inc." Harvard Business School Case 690-059, February 1990. (Revised March 1990.)
- October 16, 2024
- Article
Physicians Can Help Cut Costs. They Just Need the Right Incentives.
By: Susanna Gallani and Derek A. Haas
Health care organizations have long tried to enlist physicians in their effort to control or reduce costs. One effective means for doing so is to create an incentive system that rewards physicians for their contributions. To design such a system, organizations should... View Details
Gallani, Susanna, and Derek A. Haas. "Physicians Can Help Cut Costs. They Just Need the Right Incentives." Harvard Business Review Digital Articles (October 16, 2024).
- 06 Oct 2015
- First Look
October 6, 2015
at the Narayana Health City Cardiac Hospital (NH) in India. The case discusses the factors driving the adoption of task shifting at NH and identifies the implications of task shifting for surgeon training, surgical capacity, and procedure... View Details
Keywords: Sean Silverthorne
- April 2012 (Revised February 2013)
- Case
H-E-B: Creating a Movement to Reduce Obesity in Texas
By: Jose B. Alvarez, Jason Riis and Walter J. Salmon
In January 2012, H-E-B Grocery Co., a private retail chain with stores located in Texas and Mexico, was introducing its Healthy at H-E-B program to its customers. The program, which started with the company's employees a few years earlier, was an effort to educate and... View Details
Keywords: Corporate Social Responsibility and Impact; Profit; Leading Change; Customer Focus and Relationships; Food and Beverage Industry; Retail Industry; Texas
Alvarez, Jose B., Jason Riis, and Walter J. Salmon. "H-E-B: Creating a Movement to Reduce Obesity in Texas." Harvard Business School Case 512-034, April 2012. (Revised February 2013.)
- 17 Mar 2009
- First Look
First Look: March 17, 2009
compensation structure, and corporate governance approach, leading up to August 2008. Purchase this case: http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=709449 The Cleveland Clinic: Growth Strategy 2008 Harvard Business School Case... View Details
Keywords: Martha Lagace
- Article
Time-Driven Activity-Based Costing for Surgical Episodes
By: Peter Najjar, Matt Strickland and Robert S. Kaplan
Health care costs related to surgical care account for 40% of all hospital and physician spending. Payers attempting to contain costs are replacing fee-for-service with value-based payment schemes that can encompass entire episodes of care, including physician services... View Details
Keywords: Surgery; Time-Driven Activity-Based Costing; Bundled Payments; Health Care and Treatment; Cost Management
Najjar, Peter, Matt Strickland, and Robert S. Kaplan. "Time-Driven Activity-Based Costing for Surgical Episodes." JAMA Surgery 152, no. 1 (January 2017): 96–97.
- 25 Jan 2024
- Research & Ideas
Being a Team Player: Why College Athletes Succeed in Business
finance, law, or tech services, while female athletes more often chose education and health care. Graduates who participated in such “lower academic admission standard” sports were more likely to go into View Details
Keywords: by Rachel Layne
- December 1999 (Revised August 2001)
- Case
Millennium Pharmaceuticals, Inc. (A)
By: Stefan H. Thomke and Ashok Nimgade
Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details
Keywords: Cost Management; Financing and Loans; Medical Specialties; Retention; Growth and Development Strategy; Time Management; Product Development; Problems and Challenges; Alliances; Technology; Biotechnology Industry; Pharmaceutical Industry; Cambridge
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (A)." Harvard Business School Case 600-038, December 1999. (Revised August 2001.)
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- 05 Jun 2012
- First Look
First Look: June 5
system in particular countries are instructive. It also contains exhibits that display comparative performance of the system in terms of cost and quality. It raises the question of how health care can be delivered with higher quality at... View Details
Keywords: Sean Silverthorne
- 24 Jul 2007
- First Look
First Look: July 24, 2007
much more radical change (sacking of Troy / innovation). Democratizing Entry: Banking Deregulations, Financing Constraints, and Entrepreneurship Authors: William Kerr and Ramana Nanda Abstract We study how US branch banking deregulations... View Details
Keywords: Martha Lagace
- 2023
- Article
Comparison of COVID-19 Hospitalization Costs across Care Pathways: A Patient-level Time-driven Activity-based Costing Analysis in a Brazilian Hospital
By: Ricardo Bertoglio Cardoso, Miriam Allein Zago Marcolino, Milena Soriano Marcolino, Camila Felix Fortis, Leila Beltrami Moreira, Ana Paula Coutinho, Nadine Oliveira Clausell, Junaid Nabi, Robert S. Kaplan, Ana Paula Beck da Silva Etges and Carisi Anne Polanczyk
The COVID-19 pandemic raised awareness of the need to better understand where and how patient-level costs are incurred in health care organizations. This study used time-driven activity-based costing to estimate COVID-19 patient-level hospital costs in a Brazilian... View Details
Cardoso, Ricardo Bertoglio, Miriam Allein Zago Marcolino, Milena Soriano Marcolino, Camila Felix Fortis, Leila Beltrami Moreira, Ana Paula Coutinho, Nadine Oliveira Clausell, Junaid Nabi, Robert S. Kaplan, Ana Paula Beck da Silva Etges, and Carisi Anne Polanczyk. "Comparison of COVID-19 Hospitalization Costs across Care Pathways: A Patient-level Time-driven Activity-based Costing Analysis in a Brazilian Hospital." BMC Health Services Research 23, no. 198 (2023).
- November 2019
- Article
A Review of Bundled Payments in Total Joint Replacement
By: Olivia Manickas-Hill, Kevin J. Bozic and Thomas W. Feeley
The Bundled Payments for Care Improvement (BPCI) initiative, developed by the U.S. Center for Medicare & Medicaid Innovation, aims to reduce health care expenditures while maintaining or improving patient outcomes.
Several published reports evaluating the impact... View Details
Several published reports evaluating the impact... View Details
Manickas-Hill, Olivia, Kevin J. Bozic, and Thomas W. Feeley. "A Review of Bundled Payments in Total Joint Replacement." Journal of Bone and Joint Surgery Reviews 7, no. 11 (November 2019).
- 14 Feb 2023
- Research & Ideas
When a Vacation Isn’t Enough, a Sabbatical Can Recharge Your Life—and Your Career
A few years ago, DJ DiDonna seemed to have everything going for him. He had started a successful venture called the Entrepreneurial Finance Lab, which used psychometric factors to help banks issuing microloans in the developing world... View Details
Keywords: by Michael Blanding
- 26 Nov 2013
- First Look
First Look: November 26
Publications August 2013 Journal of Corporate Finance Golden Parachutes and the Wealth of Shareholders By: Bebchuk, Lucian A., Alma Cohen, and Charles C.Y. Wang Abstract—Golden parachutes (GPs) have attracted substantial attention from... View Details
Keywords: Sean Silverthorne
- 2006
- Working Paper
Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia
By: Nava Ashraf, James Berry and Jesse M. Shapiro
The controversy over whether and how much to charge for health products in the developing world rests, in part, on whether higher prices can increase use, either by targeting distribution to high-use households (a screening effect), or by stimulating use... View Details
Ashraf, Nava, James Berry, and Jesse M. Shapiro. "Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia." Harvard Business School Working Paper, No. 07-034, December 2006. (Forthcoming, American Economic Review.)
- 13 Nov 2006
- Research & Ideas
Science Business: What Happened to Biotech?
uncertainty, the complex and heterogeneous nature of the scientific knowledge base, and the rapid pace of scientific progress. "The health of the sector depends on how well it can cope with all three of these challenges," writes... View Details